glp 1 face Demystifying “GLP1 Face” | Impressions + Body GLP-1 + EMFACE before &

doi: 10.1210/clinem/dgaa891 208 GierBButlerPCLaiCKKirakossianDDeNicolaMMYehMW

In bronchoalveolar lavage, there was a reduction in IL-4, 5, and 33

BMI measurements are counted at the start of GLP-1 therapy so even people who fall below the threshold now can qualify if they can show they had a high enough BMI when they began taking the drugs

GLP-1 drugs research: summary GLP1 drugs may move beyond diabetes and weight loss into multidisease therapies This could significantly increase the number and profile of users, including nonobese and older populations Innovations such as oral GLP1s may further accelerate uptake and accessibility For food and beverage, the shift needs to be watched closely to understand behaviour change, consumption patterns and nutritional needs GLP-1s started life as diabetes medications, then took the world by storm for treating obesity

Since its the first all in-person ENDO since 2019, there is a lot of excitement for everyone to get back together in the real world to exchange ideas, stories, research, and, of course, hugs and handshakes

In 2023, Black adults received only about 12 percent of prescriptions for popular anti-obesity drugs, while 85 percent went to White patients.21 This stark disparity underscores systemic inequities in the healthcare system, from provider bias to financial barriers, that disproportionately affect communities of color